Insulet Corp. (PODD)

96.83
1.30 1.30
NASDAQ : Health Technology
Prev Close 98.15
Open 98.46
Day Low/High 95.05 / 98.53
52 Wk Low/High 47.31 / 102.89
Volume 882.99K
Avg Volume 419.40K
Exchange NASDAQ
Shares Outstanding 58.74M
Market Cap 5.59B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Insulet Achieves Key Milestones To Support Its Transition To Direct Operations In Europe On July 1, 2018

Insulet Achieves Key Milestones To Support Its Transition To Direct Operations In Europe On July 1, 2018

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has achieved key milestones as it transitions to direct...

The Week Ahead: Key Earnings, Data and, Oh, a Fed Rate Decision. Welcome to May

The Week Ahead: Key Earnings, Data and, Oh, a Fed Rate Decision. Welcome to May

If you thought last week was busy, hang onto your hats.

Insulet To Announce First Quarter 2018 Financial Results On May 3, 2018

Insulet To Announce First Quarter 2018 Financial Results On May 3, 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet To Share Omnipod Clinical Data At Three Major European National Diabetes Congresses

Insulet To Share Omnipod Clinical Data At Three Major European National Diabetes Congresses

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), announced that it will have a strong...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ:PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor...

Insulet Reports Fourth Quarter Revenue Of $130.5 Million, Up 26%, And Gross Margin Up 210 Basis Points, Exceeding Expectations

Insulet Reports Fourth Quarter Revenue Of $130.5 Million, Up 26%, And Gross Margin Up 210 Basis Points, Exceeding Expectations

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced promising new data for...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/12/2018 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 5.63 "days to cover" versus the median component at 4.53. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that the...

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 36th Annual J.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 29th Annual Piper Jaffray...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the Jefferies 2017 London...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 10.90 "days to cover" versus the median component at 5.18. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), a leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced its intention to...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is recognizing...

Robbins Arroyo LLP: Insulet Corporation (PODD) Misled Shareholders According To A Shareholder Derivative Lawsuit

Robbins Arroyo LLP: Insulet Corporation (PODD) Misled Shareholders According To A Shareholder Derivative Lawsuit

Shareholder rights law firm Robbins Arroyo LLP announces that a shareholder derivative complaint was filed on behalf of Insulet Corporation (NasdaqGS: PODD).

Insulet And Dexcom Partner To Offer Choices For Animas Users

Insulet And Dexcom Partner To Offer Choices For Animas Users

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company) the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is partnering with...

Insulet Offers Welcome Program For Animas® Users To Try Omnipod® Insulin Management System At Zero Cost

Insulet Offers Welcome Program For Animas® Users To Try Omnipod® Insulin Management System At Zero Cost

Insulet Corporation's (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), is offering...

Insulet Corporation To Announce Third Quarter 2017 Financial Results On November 2, 2017

Insulet Corporation To Announce Third Quarter 2017 Financial Results On November 2, 2017

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), will host a groundbreaking...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today presented real-world...

Http://www.forbes.com

Http://www.forbes.com

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the appointments of Michael R.

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/14/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 11.40 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

TheStreet Quant Rating: C- (Hold)